Author:
Bahal Sameer,Zinicola Marta,Moula Shefta E,Whittaker Thomas E.,Schejtman Andrea,Naseem Asma,Blanco Elena,Vetharoy Winston,Hu Yi-Ting,Rai Rajeev,Gomez-Castaneda Eduardo,Cunha-Santos Catarina,Burns Siobhan O.,Morris Emma C.,Booth Claire,Turchiano Giandomenico,Cavazza Alessia,Thrasher Adrian J.,Santilli Giorgia
Reference62 articles.
1. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world;El-Sayed;World Allergy Organ J,2019
2. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. 1993;Tsukada;J Immunol,2012
3. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases;Vetrie;Nature,1993
4. Clinical and genetic profile of X-linked agammaglobulinemia: a multicenter experience from India;Rawat;Front Immunol,2020
5. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines;Marron;J Allergy Clin Immunol,2012